Ronnie J. Kirschling

Oncology
9220 James Ave S.,
Bloomington, MN 55431

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.

Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.

Journal: Investigational new drugs
Published: April 13, 2013
Showing 1-1 of 1

Last Updated: 09/26/2026